DRUG-ELUTING BALLOON CATHETERS IN THE ENDOVASCULAR TREATMENT OF PATIENTS WITH TRUE LEFT MAIN BIFURCATION LESIONS ArticleMaximkin D., Shugushev Z., Safonova O., Alexandr C.Journal of the American College of Cardiology. Vol. 72. 2018.
DRUG-ELUTING BALLOON CATHETERS IN THE TREATMENT OF LEFT MAIN CORONARY ARTERY BIFURCATION LESIONS ArticleСафонова О.О., Максимкин Д.А., Чепурной А.Г., Шугушев З.Х.Кардиология и сердечно-сосудистая хирургия. Vol. 15. 2022. P.. 554-559
DRUG-ELUTING BALLOON CATHETERS IN THE TREATMENT OF LEFT MAIN CORONARY ARTERY BIFURCATION LESIONS: 4-YEAR FOLLOW-UP ArticleMaximkin D., Shugushev Z., Safonova O., Chepurnoi A., Faibushevich A., Gitelzon E., Veretnik G., Baranovich V., Sturov N.Journal of the American College of Cardiology. Vol. 78. 2021.
DRUG-ELUTING BALLOON CATHETERS IN THE TREATMENT OF LEFT MAIN CORONARY ARTERY BIFURCATION LESIONS: 4-YEARS FOLLOW-UP ArticleMaximkin D., Shugushev Z., Chepurnoy A., Gitelzon E., Faybushevich A.European Heart Journal. Vol. 42. 2021. P.. 1434-1434
DRUG-ELUTING STENTS IN THE TREATMENT OF CORONARY BIFURCATION LESIONS ArticleShugushev Z.K., Movsesyants M.Y., Maksimkin D.A., Baranovich V.Y., Faibushevich A.G., Veretnik G.I., Tarichko Y.V.Грудная и сердечно-сосудистая хирургия. 2011. P.. 31-38
DRUG-FREE THERAPY OF LIPID METABOLISM IN PATIENTS WITH CARDIOVASCULAR PATHOLOGY, AFTER COVID-19, IN COURSE OF AFTERTREATMENT (REHABILITATION) IN SANATORIUM CONDITIONS; [НЕМЕДИКАМЕНТОЗНАЯ КОРРЕКЦИЯ ЛИПИДНОГО ОБМЕНА У БОЛЬНЫХ С СЕРДЕЧНО-СОСУДИСТОЙ ПАТОЛОГИЕЙ, ПЕРЕНЕСШИХ COVID-19, НА СТАДИИ ДОЛЕЧИВАНИЯ (РЕАБИЛИТАЦИИ) В САНАТОРНЫХ УСЛОВИЯХ] ArticleKulikova N.G., Vinzhegina V.S., Chkheidze T.B., Kolodeznikova A.A., Tkachenko A.S.Вестник восстановительной медицины. Vol. 21. 2022. P.. 36-44
DRUG-INDUCED ANAPHYLAXIS: NATIONAL DATABASE ANALYSIS ArticleButranova Olga, Zyryanov Sergey, Gorbacheva Anastasia, Asetskaya Irina, Polivanov VitalyPharmaceuticals. Vol. 17. 2024. 90 p..
DRUG-INDUCED LUNG DISEASE (ORGANIZING PNEUMONIA) ASSOCIATED WITH MESALAZINE; [ЛЕКАРСТВЕННАЯ ПНЕВМОПАТИЯ (ОРГАНИЗУЮЩАЯСЯ ПНЕВМОНИЯ), АССОЦИИРОВАННАЯ С ПРИЕМОМ МЕСАЛАЗИНА] ArticleSmirnova E.V., Strelkova D.A., Ratchina S.A., Avdeev S.N., Aryutina O.V., Karpova O.Y.U.Tuberculosis and Lung Diseases. Vol. 100. 2022. P.. 55-60
DRUG-INDUCED PULMONARY FIBROSIS: NATIONAL DATABASE ANALYSIS ArticleButranova O.I., Terekhina E.N., Zyryanov S.K., Gildeeva G.N., Abramova A.A., Kustov Y.O., Asetskaya I.L., Polivanov V.A.Biomedicines. Vol. 12. 2024.
DRUG INDUCED SKIN REACTIONS CHARACTERISTICS IN MULTIFIELD EMERGENCY HOSPITAL ArticleRudyk M.Ya., Ezhova L.G., Mirilashvili T.S., Kotovskaya Yu.V., Kobalava Z.D.Вестник Российского университета дружбы народов. Серия: Медицина. 2012. P.. 46-50
DRUG INTERACTIONS IN PATIENTS WITH HCV-INFECTION TREATED WITH TRIPLE COMBINATION THERAPY ArticleАришева О.С., Гармаш И.В.Клиническая фармакология и терапия. Vol. 22. 2013. P.. 49-56
DRUG INTERCHANGEABILITY: CLINICAL EFFICACY AND SAFETY ArticleZyryanov S.K., Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Vol. 9. 2017. P.. 4-10
DRUG PROMOTION OF EGYPTIAN AND FOREIGN COMPANIES IN EGYPT ArticleLagutkina T.P., Bahlol M.M.Современные проблемы фармацевтической безопасности: рациональное применение лекарственных средств (с использованием энтеросорбентов) и профессиональная квалификация специалистов. 2017. P.. 101-105
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME WITH A NONSPECIFIC PETECHIAL RASH IN A CHILD TAKING SULFASALAZINE ArticleAbbas W.F., Tamrazova O.B., Stadnikova A.S., Rudikova E.V., Dudnik E.S.Journal of the Egyptian Women's Dermatologic Society. Vol. 20. 2023. P.. 57-59
DRUG-RELATED CARCINOGENESIS: RISK FACTORS AND APPROACHES FOR ITS PREVENTION ArticleBelitskiy G.A., Kirsanov K.I., Lesovaya E.A., Yakubovskaya M.G.Biochemistry (Moscow). Vol. 85. 2020. P.. 79-107